EP 1513828 A1 20050316 - NEW COMPOUNDS USEFUL FOR THE TREATMENT OF OBESITY, TYPE II DIABETES AND CNS DISORDERS
Title (en)
NEW COMPOUNDS USEFUL FOR THE TREATMENT OF OBESITY, TYPE II DIABETES AND CNS DISORDERS
Title (de)
NEUE, ZUR BEHANDLUNG VON OBESITAS, TYP II-DIABETES UND ZNS-ERKRANKUNGEN GEEIGNETE VERBINDUNGEN
Title (fr)
COMPOSES UTILES POUR LE TRAITEMENT DE L'OBESITE, DU DIABETE DE TYPE II ET DES TROUBLES DU SYSTEME NERVEUX CENTRAL
Publication
Application
Priority
- SE 0301061 W 20030619
- SE 0201925 A 20020620
- SE 0202181 A 20020711
- SE 0202908 A 20021001
- SE 0300357 A 20030210
- US 40612002 P 20020826
- US 43401002 P 20021217
- US 46470103 P 20030423
Abstract (en)
[origin: WO2004000828A1] The present invention relates to compounds of the general formula (I), wherein P is sulfone or sulfonamide; and A, B, W, X, Y and R3 are as defined in the description;to pharmaceutical compositions comprising these compounds, and to the use of the compounds for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes, and/or CNS disorders, to achieve reduction of body weight and of body weight gain.
IPC 1-7
C07D 401/04; C07D 495/04; C07D 405/04; C07D 471/04; C07D 493/04; C07D 513/04; C07D 207/12; C07D 211/40
IPC 8 full level
A61K 31/40 (2006.01); A61K 31/4025 (2006.01); A61K 31/4365 (2006.01); A61K 31/4465 (2006.01); A61K 31/4535 (2006.01); A61K 31/4545 (2006.01); A61K 31/496 (2006.01); A61K 31/551 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01); A61P 25/00 (2006.01); A61P 43/00 (2006.01); C07D 207/12 (2006.01); C07D 211/40 (2006.01); C07D 211/46 (2006.01); C07D 215/46 (2006.01); C07D 217/22 (2006.01); C07D 401/04 (2006.01); C07D 409/12 (2006.01); C07D 471/04 (2006.01); C07D 495/04 (2006.01)
CPC (source: EP)
A61P 3/04 (2017.12); A61P 3/10 (2017.12); A61P 25/00 (2017.12); A61P 43/00 (2017.12); C07D 471/04 (2013.01); C07D 495/04 (2013.01)
Citation (search report)
See references of WO 2004000828A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated extension state (EPC)
LV
DOCDB simple family (publication)
WO 2004000828 A1 20031231; AU 2003243091 A1 20040106; BR 0311952 A 20050419; CA 2486989 A1 20031231; CN 1662521 A 20050831; EA 008835 B1 20070831; EA 011581 B1 20090428; EA 200500054 A1 20050630; EA 200600975 A1 20061027; EP 1513828 A1 20050316; IL 165051 A0 20051218; MX PA04012914 A 20050331; NO 20050294 L 20050204; NZ 536600 A 20070831; NZ 552282 A 20080731; NZ 552283 A 20080731; RS 111204 A 20061215; SG 156524 A1 20091126
DOCDB simple family (application)
SE 0301061 W 20030619; AU 2003243091 A 20030619; BR 0311952 A 20030619; CA 2486989 A 20030619; CN 03814432 A 20030619; EA 200500054 A 20030619; EA 200600975 A 20030619; EP 03760999 A 20030619; IL 16505104 A 20041104; MX PA04012914 A 20030619; NO 20050294 A 20050119; NZ 53660003 A 20030619; NZ 55228203 A 20030619; NZ 55228303 A 20030619; SG 2006041883 A 20030619; YU P111204 A 20030619